Skip to main content

Advertisement

SpringerLink
Log in

Biochemical Indicator of Sickle Cell Disease: Preliminary Report from India

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Blood biochemistry has significant effect on pathophysiology of human body. Recently few studies found the association of biochemical abnormalities in sickle cell patients. Sickle cell disease showed clinical variability where African ancestors have severe phenotype than Indian sicklers. Our aim was to evaluate the biochemicals in sickle cell patients and their effect on severity. Here we present the comparative biochemical levels in sickle cell patients as well as controls. Sickle cell patients diagnosed by HPLC and biochemical analysis done by Beckman-auto analyzer. T test applied for statistical analysis. Result showed the renal abnormality lesser in patients and related biochemical within the normal range and statistically not significant. Electrolytes, hepatic enzymes, alkaline phosphatase and glucose were elevated and statistically significant (P value <0.05). Observation of the study concludes the biochemical abnormality play a significant role in sickle cell patient’s physiopathology and can be used to management of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Oladipo O, Temiye EO, Ezeaka VC, Obomanu P. Serum, magnesium, phosphate and calcium in Nigerian children with sickle cell disease. West Afr J Med. 2005;24(2):120–3.

    PubMed  CAS  Google Scholar 

  2. Nelson DA, Rizvi S, Bhattacharyya T, Ortega J, Lachant N, Swerdlow P. Trabecular and integral bone density in adults with sickle cell disease. J Clin Densitom. 2003;6(2):125–9.

    Article  PubMed  Google Scholar 

  3. Nouraie M, Cheng K, Niu X, Moore-King E, Fadojutimi-Akinsi MF, Minniti CP, et al. Predictors of osteoclast activity in sickle cell disease patients. Haematologica. 2011;96. doi:10.3324/haematol.2011.042499.

  4. Afonja OA, Boyd AE. Plasma alkaline phosphatase and osteoblastic activity in sickle cell anaemia. J Trop Pediatr. 1986;32(3):115–6.

    PubMed  CAS  Google Scholar 

  5. Adewoye AH, Chen TC, Ma Q, McMahon L, Mathieu J, Malabanan A, Steinberg MH, Holick MF. Sickle cell bone disease: response to vitamin D and calcium. Am J Hematol. 2008;83(4):271–4.

    Article  PubMed  CAS  Google Scholar 

  6. Allon M. Renal abnormalities in sickle cell disease. Arch Intern Med. 1990;150(3):501–4.

    Article  PubMed  CAS  Google Scholar 

  7. Buchowski MS, de la Fuente FA, Flakoll PJ, Chen KY, Turner EA. Increased bone turnover is associated with protein and energy metabolism in adolescents with sickle cell anemia. Am J Physiol Endocrinol Metab. 2001;280:E518–27.

    PubMed  CAS  Google Scholar 

  8. Schubert TT. Hepatobiliary system in sickle cell disease. Gastroenterology. 1986;90(6):2013–21.

    PubMed  CAS  Google Scholar 

  9. Kakarala S, Lindberg M. Safety of liver biopsy in acute sickle hepatic crisis. Conn Med. 2004;68(5):277–9.

    PubMed  Google Scholar 

  10. Beutler E. The sickle cell diseases and related disorders. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, editors. Williams hematology. New York: McGrawHill; 1999. p. 581–605.

    Google Scholar 

  11. Nsiah K, Dzogbefia VP, Ansong D, Osei Akoto A, Boateng H, Ocloo D. Pattern of AST and ALT changes in relation to hemolysis in sickle cell disease. Clin Med Insight Blood Disord. 2011;4:1–9.

    Article  CAS  Google Scholar 

  12. Guasch A. In: Eckman J, Platt A, editors. Proteinuria and renal insufficiency. http://scinfo.org/problem-oriented-clinical-guidelines/specific-problems-proteinuria-and-renal-insufficiency.

  13. Vitoux D, Olivieri O, Garay RP, Cragoe EJ Jr, Galacterous F, Bevizard Y. Inhibition of K+ efflux and dehydration of sickle cells by [(dihydroindenyl)oxy] alkanoic acid: an inhibitor of the K+-Cl− co transport system. Proc Natl Acad Sci USA. 1989;86(11):4273–6.

    Article  PubMed  CAS  Google Scholar 

  14. Rhoda MD, Apovo M, Beuzard Y, Giraud F. Ca2+ permeability in de oxygenated sickle cells. Blood. 1990;75(12):2453–8.

    PubMed  CAS  Google Scholar 

  15. Gibson JS, Speake PF, Ellory JC. Differential oxygen sensitive of the K+ and Cl− co transporter in normal and sickle human red blood cells. J Physiol. 1998;511(1):225–33.

    Article  PubMed  CAS  Google Scholar 

  16. Vener KJ. Urea and sickle cell anemia. J Theor Biol. 1977;66(3):457–60.

    Article  PubMed  CAS  Google Scholar 

  17. Osuagwul CG, Mbeyi CU. Altered plasma hexose sugar metabolism in sickle cell anaemia. Afr J Biochem. 2007;1(3):37–40.

    Google Scholar 

  18. Al-Harbi N, Annobil SH, Abbag F, Adzaku F, Bassuni W. Renal reabsorption of phosphate in children with sickle cell anemia. Am J Nephrol. 1999;19(5):552–4.

    Article  PubMed  CAS  Google Scholar 

  19. Maddrey WC, Cukier JO, Maglalang AC, Boitnott JK, Odell GB. Hepatic bilirubin UDP-glucuronyltransferase in patients with sickle cell anemia. Gastroenterology. 1978;74(2 Pt 1):193–5.

    PubMed  CAS  Google Scholar 

  20. Conger JD. Acute uric acid nephropathy. Med Clin N Am. 1990;74(4):859–71.

    PubMed  CAS  Google Scholar 

  21. Diamond HS, Meisel AD, Holden D. The natural history of urate overproduction in sickle cell anemia. Ann Intern Med. 1979;90(5):752–7.

    PubMed  CAS  Google Scholar 

  22. Mohanty D, Mukheriee M. Sickle cell disease in India. Haematology. 2002;9(2):117–22.

    Google Scholar 

  23. Banerjee S, Owen C, Chopra S. Sickle cell hepatopathy. Hepatology. 2001;33(5):1021–8.

    Article  PubMed  CAS  Google Scholar 

  24. Mohammed SM, Suleiman SA, Addae SK, Annobil SH, Adzaku FK, Kadoummi OF, Richards JT. Urinary hydroxyproline and serum alkaline phosphatase in sickle cell disease. Clin Chim Acta. 1991;203(2–3):285–94.

    Article  PubMed  CAS  Google Scholar 

  25. Kotila T, Adedapo K, Adedapo A, Oluwasola O, Fakunle E, Brown B. Liver dysfunction in steady state sickle cell disease. Ann Hepatol. 2005;4(4):261–3.

    PubMed  CAS  Google Scholar 

  26. Azinge EC, Bolarin DM. Osteocalcin and bone-specific alkaline phosphatase in sickle cell haemoglobinopathie. Niger J Physiol Sci. 2006;21(1–2):21–5.

    PubMed  CAS  Google Scholar 

  27. Sesso R, Almeida MA, Figueiredo MS, Bordin JO. Renal dysfunction in patients with sickle cell anemia or sickle cell trait. Braz J Med Biol Res. 1998;31:1257–62.

    Article  PubMed  CAS  Google Scholar 

  28. Serjeant GR. Albuminuria and renal function in homozygous sickle cell disease. Observations from a cohort study. Arch Intern Med. 2007;167:701–8.

    Article  PubMed  Google Scholar 

  29. Marouf R, Mojiminiyi O, Abdella N, Kortom M, Al Wazzan H. Comparison of renal function markers in Kuwaiti patients with sickle cell disease. J Clin Pathol. 2006;59:345–51.

    Article  PubMed  CAS  Google Scholar 

  30. Al-Naama LM, Al-Sadoon EA, Al-Sadoon TA. Levels of uric acid, urea and creatinine in Iraqi children with sickle cell disease. J Pak Med Assoc. 2000;50(3):98–102.

    PubMed  CAS  Google Scholar 

  31. El-Hazmi MAF, Al-Faleh FZ, Warsv AS. Plasma uric acid, urea and creatinine in sickle cell disease. Saudi Med J. 1989;10:471–6.

    Google Scholar 

  32. Reynolds MD. Gout and hyperuricemia associated with sickle cell anaemia. Semin Arthritis Rheum. 1983;12:404–13.

    Article  PubMed  CAS  Google Scholar 

  33. Weiss E, Rees DC, Gibson JS. Role of calcium in phosphatidylserine externalisation in red blood cells from sickle cell patients. Anemia. 2011. doi:10.1155/2011/379894.

  34. van der Dijs FP, van der Klis FR, Muskiet FD, Muskiet FA. Serum calcium and vitamin D status of patients with sickle cell disease in Curaçao. Ann Clin Biochem. 1997;34(Pt 2):170–2.

    PubMed  Google Scholar 

  35. Nduka N, Kazem Y, Saleh B. Variation in serum electrolytes and enzyme concentrations in patients with sickle cell disease. J Clin Pathol. 1995;48(7):648–51.

    Article  PubMed  CAS  Google Scholar 

  36. Agoreyo FO, Nwanze N. Plasma sodium and potassium changes in sickle cell patients. Int J Genet Mol Biol. 2010;2(2):14–9.

    CAS  Google Scholar 

  37. Oster JR, Lanier DC Jr, Vaamonde CA. Renal response to potassium loading in sickle cell trait. Arch Intern Med. 1980;140(4):534–6.

    Article  PubMed  CAS  Google Scholar 

  38. Izumo H, Lear S, Williams M, Rosa R, Epstein FH. Sodium-potassium pump, ion fluxes, and cellular dehydration in sickle cell anemia. J Clin Invest. 1987;79(6):1621–8.

    Article  PubMed  CAS  Google Scholar 

  39. Johnson CS, Omata M, Tong MJ, Simmons JF Jr, Weiner J, Tatter D. Liver involvement in sickle cell disease. Medicine. 1985;64:349–56.

    Article  PubMed  CAS  Google Scholar 

  40. Smith EC, Valika KS, Woo JE, O’Donnell JG, Gordon DL, Westerman MP. Serum phosphate abnormalities in sickle cell anemia. Exp Biol Med. 1981;168:254–8.

    CAS  Google Scholar 

  41. Hargrove MD. Marked increase in serum bilirubin in sickle cell anemia. A report of 6 patients. Am J Dig Dis. 1970;15(5):437–42.

    Article  PubMed  Google Scholar 

  42. Isichef UP. Serum protein profile in sickle cell disease. J Clin Pathol. 1979;32:117–21.

    Article  Google Scholar 

  43. Lachant NA, Davidson WD, Tanaka KR. Impaired pentose phosphate shunt function in sickle cell disease. Am J Hematol. 1983;15:1–3.

    Article  PubMed  CAS  Google Scholar 

  44. Adekile AD, Olusi SO, Oyebola DD. Oral glucose intolerance test in children with sickle cell anaemia. East Afr Med J. 1985;62(3):213–7.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, All India Institute of Medical Sciences (AIIMS), I.R.C.H. Building (1st Floor), Ansari Nagar, New Delhi, 110 029, India

    S. Pandey, A. Sharma, S. Dahia, V. Sharma, Sw. Pandey & R. Saxena

  2. Department of Cardiac Biochemistry, AIIMS, New Delhi, India

    V. Shah

  3. Department of Environmental Biology, APS University, Rewa, India

    R. M. Mishra

Authors
  1. S. Pandey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Dahia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. M. Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sw. Pandey
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Saxena
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Saxena.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pandey, S., Sharma, A., Dahia, S. et al. Biochemical Indicator of Sickle Cell Disease: Preliminary Report from India. Ind J Clin Biochem 27, 191–195 (2012). https://doi.org/10.1007/s12291-011-0162-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-011-0162-y

Keywords

Search

Navigation